Free Trial

Elanco Animal Health (ELAN) Stock Forecast & Price Target

Elanco Animal Health logo
$11.63 -0.19 (-1.61%)
(As of 12/20/2024 05:45 PM ET)

Elanco Animal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
4
Buy
3

Based on 8 Wall Street analysts who have issued ratings for Elanco Animal Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 8 analysts, 1 has given a sell rating, 4 have given a hold rating, and 3 have given a buy rating for ELAN.

Consensus Price Target

$16.71
43.72% Upside
According to the 8 analysts' twelve-month price targets for Elanco Animal Health, the average price target is $16.71. The highest price target for ELAN is $20.00, while the lowest price target for ELAN is $14.00. The average price target represents a forecasted upside of 43.72% from the current price of $11.63.
Get the Latest News and Ratings for ELAN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Elanco Animal Health and its competitors.

Sign Up

ELAN Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
4 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$16.71$17.14$17.29$14.21
Forecasted Upside43.72% Upside27.88% Upside22.86% Upside-3.11% Downside
Consensus Rating
Hold
Hold
Hold
Hold

ELAN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ELAN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Elanco Animal Health Stock vs. The Competition

TypeElanco Animal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.25
2.81
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside43.72% Upside25,828.56% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent ELAN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/9/2024UBS Group
4 of 5 stars
A. Alfonso
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$18.00+44.00%
12/2/2024Leerink Partnrs
5 of 5 stars
D. Clark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
12/2/2024Leerink Partners
1 of 5 stars
 Initiated CoverageMarket Perform$14.00+5.98%
11/8/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$19.00 ➝ $20.00+40.94%
9/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00+33.87%
9/19/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$17.00 ➝ $15.00+2.39%
7/1/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$19.00 ➝ $16.00+10.88%
2/27/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$12.50 ➝ $14.00-15.15%
12/19/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$17.00+24.45%
12/7/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$18.00+39.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:50 AM ET.


ELAN Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Elanco Animal Health is $16.71, with a high forecast of $20.00 and a low forecast of $14.00.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ELAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ELAN, but not buy additional shares or sell existing shares.

According to analysts, Elanco Animal Health's stock has a predicted upside of 43.72% based on their 12-month stock forecasts.

Over the previous 90 days, Elanco Animal Health's stock had 1 upgrade by analysts.

Elanco Animal Health has been rated by research analysts at Barclays, Leerink Partners, Leerink Partnrs, and UBS Group in the past 90 days.

Analysts like Elanco Animal Health less than other "medical" companies. The consensus rating for Elanco Animal Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ELAN compares to other companies.


This page (NYSE:ELAN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners